167 related articles for article (PubMed ID: 23370034)
21. A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2022.
Wagh K; Kancherla V; Dorsey A; Pachón H; Oakley GP
Birth Defects Res; 2024 May; 116(5):e2343. PubMed ID: 38688860
[TBL] [Abstract][Full Text] [Related]
22. [Effects of folic acid fortification in the rates of malformations at birth in Chile].
Nazer H J; Cifuentes O L; Aguila R A; Juárez H ME; Cid R MP; Godoy V ML; García A K; Melibosky R F
Rev Med Chil; 2007 Feb; 135(2):198-204. PubMed ID: 17406737
[TBL] [Abstract][Full Text] [Related]
23. Tracking the prevention of folic acid-preventable spina bifida and anencephaly.
Bell KN; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2006 Sep; 76(9):654-7. PubMed ID: 17001686
[TBL] [Abstract][Full Text] [Related]
24. Reductions in child mortality by preventing spina bifida and anencephaly: Implications in achieving Target 3.2 of the Sustainable Development Goals in developing countries.
Kancherla V; Redpath B; Oakley GP
Birth Defects Res; 2019 Aug; 111(14):958-966. PubMed ID: 30070775
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
[TBL] [Abstract][Full Text] [Related]
26. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México.
Martínez de Villarreal L; Pérez JZ; Vázquez PA; Herrera RH; Campos Mdel R; López RA; Ramírez JL; Sánchez JM; Villarreal JJ; Garza MT; Limón A; López AG; Bárcenas M; García JR; Domínguez AS; Nuñez RH; Ayala JL; Martínez JG; González MT; Alvarez CG; Castro RN
Teratology; 2002 Nov; 66(5):249-56. PubMed ID: 12397633
[TBL] [Abstract][Full Text] [Related]
27. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification.
Bower C; D'Antoine H; Stanley FJ
Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646
[TBL] [Abstract][Full Text] [Related]
28. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
[TBL] [Abstract][Full Text] [Related]
29. NTD prevalences in central California before and after folic acid fortification.
Chen BH; Carmichael SL; Selvin S; Abrams B; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):547-52. PubMed ID: 18496833
[TBL] [Abstract][Full Text] [Related]
30. Comparing the observed and predicted effectiveness of folic acid fortification in preventing neural tube defects.
Palomaki GE; Williams J; Haddow JE
J Med Screen; 2003; 10(1):52-3. PubMed ID: 12790316
[No Abstract] [Full Text] [Related]
31. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification.
Ray JG; Wyatt PR; Vermeulen MJ; Meier C; Cole DE
Obstet Gynecol; 2005 Feb; 105(2):261-5. PubMed ID: 15684149
[TBL] [Abstract][Full Text] [Related]
32. Race and ethnicity and preconception folic acid supplement use among pregnant women in Georgia, PRAMS 2009 to 2011.
Mukhtar A; Kramer MR; Oakley GP; Kancherla V
Birth Defects Res; 2017 Jan; 109(1):38-48. PubMed ID: 27905191
[TBL] [Abstract][Full Text] [Related]
33. Association of neural tube defects and folic acid food fortification in Canada.
Ray JG; Meier C; Vermeulen MJ; Boss S; Wyatt PR; Cole DE
Lancet; 2002 Dec 21-28; 360(9350):2047-8. PubMed ID: 12504403
[TBL] [Abstract][Full Text] [Related]
34. Update on prevention of folic acid-preventable spina bifida and anencephaly.
Bell KN; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):102-7. PubMed ID: 19067404
[TBL] [Abstract][Full Text] [Related]
35. Weekly administration of folic acid and epidemiology of neural tube defects.
Martínez de Villarreal LE; Arredondo P; Hernández R; Villarreal JZ
Matern Child Health J; 2006 Sep; 10(5):397-401. PubMed ID: 16900407
[TBL] [Abstract][Full Text] [Related]
36. Perinatal factors associated with neural tube defects (anencephaly [correction of anancephaly], spina bifida and encephalocele).
Ogata AJ; Camano L; Brunoni D
Rev Paul Med; 1992; 110(4):147-51. PubMed ID: 1341003
[TBL] [Abstract][Full Text] [Related]
37. An Audit of Neural Tube Defects in the Republic Of Ireland for 2012-2015.
McDonnell R; Delany V; O'Mahony MT; Lynch C; McKeating A; McKeating A; Turner MJ
Ir Med J; 2018 Mar; 111(3):712. PubMed ID: 30376230
[TBL] [Abstract][Full Text] [Related]
38. Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand.
Oakley GP; Weber MB; Bell KN; Colditz P
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):838-41. PubMed ID: 15390316
[TBL] [Abstract][Full Text] [Related]
39. Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(30):513-6. PubMed ID: 2072886
[TBL] [Abstract][Full Text] [Related]
40. [Effect of flour folic acid fortification on the incidence of cranio encephalic congenital defects].
Corral S E; Moreno S R; Pérez G G; Ojeda B ME; Valenzuela G H; Reascos M M; Sepúlveda L W
Rev Med Chil; 2006 Sep; 134(9):1129-34. PubMed ID: 17171214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
